GMP secures AstraZeneca’s Madrid office complex, bolstering its office portfolio amid rising corporate HQ interest in the city
Executive summary: GMP bought AstraZeneca’s Madrid office complex (20,000 sqm) in Las Tablas for an undisclosed sum. The acquisition expands GMP’s office holdings in a prime Madrid submarket and signals confidence in sustained demand for corporate office space despite high household living costs. GMP (Socimi), AstraZeneca (seller), Madrid local market, and other firms eyeing relocations such as Changan and JetBrains. GMP may seek tenants or reposition the asset; further office transactions could follow as more companies announce Madrid HQ plans.
The Socimi GMP announced the purchase of AstraZeneca’s former headquarters in Las Tablas, Madrid, a 20,000‑square‑meter office complex. The deal adds prime office space to GMP’s portfolio and reflects continued demand for quality office assets in the Spanish capital. The transaction occurs as several firms, including Changan and JetBrains, announce plans to expand or relocate their European operations to Madrid. While housing costs are consuming a large share of household budgets, the office market remains active, suggesting divergent pressures across real estate segments.
Connected developments
- Changan apuesta por Madrid para ubicar su sede europea
- JetBrains abre oficina en Madrid y busca ingenieros
- Vivienda, alimentación y transporte devoran el 60% del presupuesto de los hogares
- JetBrains abre oficina en Madrid y busca ingenieros
- Del edificio Windsor a la Torre Moeve: incendios en el distrito financiero de Madrid
- El Corte Inglés se une a IHG para abrir en 2030 un hotel de lujo Kimpton en Madrid
Open the full case file on Beyond →
Social Pulse
AI estimate · not scraped